Dynavax Technologies Corporation Asset Turnover Ratio (DVAX), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Dynavax Technologies Corporation  (NASDAQ: DVAX)
 

Dynavax Technologies Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Dynavax Technologies Corporation asset turnover ratio, the ability of Dynavax Technologies Corporation's assets to generate revenue in the third quarter 2025, increased sequentially to 0.36 in the third quarter (Sep 30 2025), yet the ratio remained below the average, as DVAX's position remain challenging.

Within sector 106 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2025 compared to the preceding quarter from 2319 to 2586.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DVAX Asset Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Asset Change -10.8 % -9.52 % -3.89 % -0.68 % 9.57 %
Y / Y Revenue Change 17.67 % 29.33 % 34.21 % 29.56 % 17.68 %
Asset Turnover Ratio (TTM) 0.36 0.33 0.3 0.28 0.26
DVAX's Total Ranking # 2586 # 2319 # 2530 # 2596 # 2715
Seq. Asset Change 3.21 % -2.89 % -4.2 % -7.1 % 4.69 %
Seq. Revenue Change -0.59 % 40.02 % -5.37 % -10.66 % 9.26 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 107
Healthcare Sector # 356
Overall Market # 2586

Asset Turnover Ratio Statistics
High Average Low
9.86 4.81 0.33
(Dec 31 2014)   (Dec 31 2017)




DVAX Company Profile • Back to DVAX Efficiency Comparisons • Compare DVAX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Quipt Home Medical Corp   0.97 $ 245.359  Millions$ 251.711  Millions
National Healthcare Corp  0.97 $ 1,500.618  Millions$ 1,551.903  Millions
Orthofix Medical Inc   0.97 $ 818.516  Millions$ 846.551  Millions
Organogenesis Holdings Inc   0.96 $ 465.218  Millions$ 484.059  Millions
Accuray Incorporated  0.96 $ 450.046  Millions$ 469.993  Millions
Myriad Genetics Inc   0.96 $ 823.200  Millions$ 859.775  Millions
Ironwood Pharmaceuticals inc   0.96 $ 338.987  Millions$ 354.282  Millions
Bioaffinity Technologies Inc   0.96 $ 6.777  Millions$ 7.090  Millions
Addus Homecare Corp  0.95 $ 1,346.751  Millions$ 1,413.022  Millions
Harvard Bioscience Inc   0.95 $ 86.749  Millions$ 91.133  Millions
Nuwellis Inc   0.95 $ 8.090  Millions$ 8.514  Millions
Cerus Corporation  0.95 $ 197.924  Millions$ 208.987  Millions
Ensysce Biosciences Inc   0.95 $ 4.488  Millions$ 4.741  Millions
National Vision Holdings Inc   0.94 $ 1,861.626  Millions$ 1,986.237  Millions
Kiniksa Pharmaceuticals International Plc  0.94 $ 597.973  Millions$ 638.341  Millions
Ufp Technologies Inc   0.93 $ 596.497  Millions$ 639.779  Millions
Alphatec Holdings Inc   0.93 $ 728.985  Millions$ 784.681  Millions
Embecta Corp   0.93 $ 1,079.800  Millions$ 1,163.425  Millions
Community Health Systems Inc   0.92 $ 12,643.000  Millions$ 13,706.000  Millions
Neuronetics Inc   0.92 $ 129.497  Millions$ 140.752  Millions
Adma Biologics Inc   0.92 $ 486.499  Millions$ 531.579  Millions
Pediatrix Medical Group Inc   0.91 $ 1,922.442  Millions$ 2,111.921  Millions
Axsome Therapeutics Inc   0.91 $ 561.263  Millions$ 618.551  Millions
Neuropace Inc   0.91 $ 94.830  Millions$ 104.555  Millions
Strata Skin Sciences Inc  0.90 $ 29.713  Millions$ 32.965  Millions
Fortrea Holdings Inc   0.90 $ 2,759.900  Millions$ 3,069.375  Millions
Arcutis Biotherapeutics Inc   0.90 $ 317.929  Millions$ 354.101  Millions
Lifeward ltd   0.90 $ 24.498  Millions$ 27.310  Millions
Corcept Therapeutics Inc  0.90 $ 741.172  Millions$ 828.084  Millions
Docgo Inc   0.89 $ 368.093  Millions$ 412.115  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.